Table 3: Comparison of various clinical outcomes according to the pre-procedural TIMI flow.
| Overall patient | Total (n = 8428) | Pre TIMI 0-2 (n = 7309) | Pre TIMI 3 (n = 1119) | p-value |
| ≤ 30 day MACE | 468 (5.6) | 429 (5.9) | 39 (3.5) | 0.001 |
| ≤ 30 day CVD | 381 (4.5) | 353 (4.8) | 28 (2.4) | 0.001 |
| 1-year MACE | 938 (11.1) | 833 (11.4) | 105 (9.4) | 0.047 |
| 1-year all-cause death | 689 (8.2) | 619 (8.5) | 70 (6.3) | 0.014 |
| 1-year CVD | 488 (5.8) | 446 (6.1) | 42 (3.8) | 0.002 |
| MI | 76 (0.9) | 64 (0.9) | 12 (1.1) | 0.61 |
| RePCI (TVR/TLR) | 231 (2.7) | 197 (2.7) | 34 (3.0) | 0.555 |
| CABG | 22 (0.3) | 19 (0.3) | 3 (0.3) | 0.999 |
| Patients who excluded ≤ 30 day events | Overall patients (n = 7960) | Pre TIMI 0-2 (n = 6880) | Pre TIMI 3 (n = 1080) | p-value |
| MACE (> 30 day) | 470 (5.9) | 404 (5.9) | 66 (6.1) | 0.781 |
| CVD (> 30 day) | 107 (1.3) | 93 (1.4) | 14 (1.3) | 0.999 |
TIMI: Thrombolysis in Myocardial Infarction; MACE: Major Adverse Cardiac Events; MI: Myocardial Infarction; TVR: Target Vessel Revascularization; TLR: Target Lesion Revascularization; RePCI: Recurrent Percutaneous Coronary Intervention. MACE is defined as the composite of the death of any cause, recurrence of MI, TLR, TVR, and CABG.